Skip to main content
Log in

Defibrillation threshold testing during implantable cardioverter defibrillator implantation: 5-year follow-up

  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

Abstract

Purpose

Defibrillation threshold (DFT) testing is a routine practice in some Asian countries for patients receiving an implantable cardioverter defibrillator (ICD). However, there are few long-term data about the necessity of intraoperative DFT testing in an Asian population. We investigated the safety of DFT testing and the long-term clinical outcomes in Asian patients undergoing ICD implantation.

Methods

All patients undergoing de novo transvenous ICD implantation were randomized to undergo periprocedural DFT testing. The study included 67 patients (50 males; 51.5 ± 16.9 years) who underwent ICD implantation with (n = 33) or without (n = 34) intraoperative DFT testing between March 2012 and February 2014. We compared first-shock success, composite safety end points (the sum of complications recorded at 30 days), arrhythmic death, and all-cause mortality.

Results

The baseline clinical characteristics and the procedural-related adverse event rate (3.0% with DFT vs. 0% with non-DFT, p = 0.214) did not differ between groups. The programmed output of the first shock was lower in the DFT testing group (22.9 ± 4.4 J vs. 25.3 ± 5.4 J, p = 0.007). However, there were no significant differences between groups for all-cause mortality (12.1% vs. 17.6%, p = 0.526) or first-shock success rate for ventricular arrhythmia (100% vs. 88.2%, p = 0.471).

Conclusions

There were no between-group differences in periprocedural safety, complications, and long-term clinical outcomes. Our results suggest that DFT testing in Asian patients allows reduction of the programmed output of the first shock, but does not affect long-term clinical outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 1996;335:1933–40.

    Article  CAS  Google Scholar 

  2. The antiarrhythmics versus implantable defibrillators (AVID) investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997;337:1576–83.

    Article  Google Scholar 

  3. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877–83.

    Article  Google Scholar 

  4. Winkle RA, Stinson EB, Bach SM Jr, Echt DS, Oyer P, Armstrong K. Measurement of cardioversion/defibrillation thresholds in man by a truncated exponential waveform and an apical patch-superior vena caval spring electrode configuration. Circulation. 1984;69:766–71.

    Article  CAS  Google Scholar 

  5. Singer I, Lang D. Defibrillation threshold: clinical utility and therapeutic implications. Pacing Clin Electrophysiol. 1992;15:932–49.

    Article  CAS  Google Scholar 

  6. Marchlinski FE, Flores B, Miller JM, Gottlieb CD, Hargrove WC 3rd. Relation of the intraoperative defibrillation threshold to successful postoperative defibrillation with an automatic implantable cardioverter defibrillator. Am J Cardiol. 1988;62:393–8.

    Article  CAS  Google Scholar 

  7. Tokano T, Bach D, Chang J, Davis J, Souza JJ, Zivin A, et al. Effect of ventricular shock strength on cardiac hemodynamics. J Cardiovasc Electrophysiol. 1998;9:791–7.

    Article  CAS  Google Scholar 

  8. Runsio M, Bergfeldt L, Brodin LA, Ribeiro A, Samuelsson S, Rosenqvist M. Left ventricular function after repeated episodes of ventricular fibrillation and defibrillation assessed by transoesophageal echocardiography. Eur Heart J. 1997;18:124–31.

    Article  CAS  Google Scholar 

  9. Birnie D, Tung S, Simpson C, Crystal E, Exner D, Ayala Paredes FA, et al. Complications associated with defibrillation threshold testing: the Canadian experience. Heart Rhythm. 2008;5:387–90.

    Article  Google Scholar 

  10. Roh SY, Choi JI, Kim MS, Cho EY, Kim YG, Lee KN, et al. Trends in the use of implantable cardioverter-defibrillators for prevention of sudden cardiac arrest: a South Korean nationwide population-based study. Pacing Clin Electrophysiol. 2019;42:1086–94.

    Article  Google Scholar 

  11. Ellenbogen KA, Wood MA, Stambler BS, Welch WJ, Damiano RJ. Measurement of ventricular electrogram amplitude during intraoperative induction of ventricular tachyarrhythmias. Am J Cardiol. 1992;70:1017–22.

    Article  CAS  Google Scholar 

  12. Swerdlow CD. Implantation of cardioverter defibrillators without induction of ventricular fibrillation. Circulation. 2001;103:2159–64.

    Article  CAS  Google Scholar 

  13. Wilkoff BL, Fauchier L, Stiles MK, Morillo CA, Al-Khatib SM, Almendral J, et al. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. Heart Rhythm. 2016;13:e50–86.

    Article  Google Scholar 

  14. Healey JS, Dorian P, Mitchell LB, Talajic M, Philippon F, Simpson C, et al. Canadian Registry of ICD Implant Testing procedures (CREDIT): current practice, risks, and costs of intraoperative defibrillation testing. J Cardiovasc Electrophysiol. 2010;21:177–82.

    Article  Google Scholar 

  15. Lin EF, Dalal D, Cheng A, Marine JE, Nazarian S, Sinha S, et al. Predictors of high defibrillation threshold in the modern era. Pacing Clin Electrophysiol. 2013;36:231–7.

    Article  CAS  Google Scholar 

  16. Bansch D, Bonnemeier H, Brandt J, Bode F, Svendsen JH, Taborsky M, et al. Intra-operative defibrillation testing and clinical shock efficacy in patients with implantable cardioverter-defibrillators: the NORDIC ICD randomized clinical trial. Eur Heart J. 2015;36:2500–7.

    Article  Google Scholar 

  17. Hinkle LE Jr, Thaler HT. Clinical classification of cardiac deaths. Circulation. 1982;65:457–64.

    Article  Google Scholar 

  18. Healey JS, Hohnloser SH, Glikson M, Neuzner J, Mabo P, Vinolas X, et al. Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE). Lancet. 2015;385:785–91.

    Article  Google Scholar 

  19. Nagai T, Kurita T, Satomi K, Noda T, Okamura H, Shimizu W, et al. QRS prolongation is associated with high defibrillation thresholds during cardioverter-defibrillator implantations in patients with hypertrophic cardiomyopathy. Circ J. 2009;73:1028–32.

    Article  Google Scholar 

  20. Mizukami K, Yokoshiki H, Mitsuyama H, Watanabe M, Tenma T, Matsui Y, et al. Predictors of high defibrillation threshold in patients with implantable cardioverter-defibillator using a transvenous dual-coil lead. Circ J. 2015;79:77–84.

    Article  Google Scholar 

  21. Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study. Eur Heart J. 2000;21:2071–8.

    Article  CAS  Google Scholar 

  22. Crossley GH, Boyce K, Roelke M, Evans J, Yousuf D, Syed Z, et al. A prospective randomized trial of defibrillation thresholds from the right ventricular outflow tract and the right ventricular apex. Pacing Clin Electrophysiol. 2009;32:166–71.

    Article  Google Scholar 

  23. Blatt JA, Poole JE, Johnson GW, Callans DJ, Raitt MH, Reddy RK, et al. No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). J Am Coll Cardiol. 2008;52:551–6.

    Article  Google Scholar 

  24. Brignole M, Occhetta E, Bongiorni MG, Proclemer A, Favale S, Iacopino S, et al. Clinical evaluation of defibrillation testing in an unselected population of 2,120 consecutive patients undergoing first implantable cardioverter-defibrillator implant. J Am Coll Cardiol. 2012;60:981–7.

    Article  Google Scholar 

  25. Lau CP, Chen CA, Zhang S, Ngarmukos T, Shimizu W, Cheng CC et al. The APHRS White Book 2019. Asia Pacific Heart Rhythm Society. Available at http://www.aphrs.org/attachments/article/APHRS White Book 2019.

  26. Murakoshi N, Aonuma K. Epidemiology of arrhythmias and sudden cardiac death in Asia. Circ J. 2013;77:2419–31.

    Article  Google Scholar 

  27. Russo AM, Chung MK. Is defibrillation testing necessary for implantable transvenous defibrillators?: defibrillation testing is necessary at the time of implantable cardioverter defibrillator implantation. Circ Arrhythm Electrophysiol. 2014;7:337–46.

    Article  Google Scholar 

  28. Gold MR, Higgins S, Klein R, Gilliam FR, Kopelman H, Hessen S, et al. Efficacy and temporal stability of reduced safety margins for ventricular defibrillation: primary results from the Low Energy Safety Study (LESS). Circulation. 2002;105:2043–8.

    Article  Google Scholar 

  29. Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, et al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation. 2004;110:2591–6.

    Article  Google Scholar 

  30. Pires LA, Johnson KM. Intraoperative testing of the implantable cardioverter-defibrillator: how much is enough? J Cardiovasc Electrophysiol. 2006;17:140–5.

    Article  Google Scholar 

  31. Russo AM, Sauer W, Gerstenfeld EP, Hsia HH, Lin D, Cooper JM, et al. Defibrillation threshold testing: is it really necessary at the time of implantable cardioverter-defibrillator insertion? Heart Rhythm. 2005;2:456–61.

    Article  Google Scholar 

  32. Radbill AE, Triedman JK, Berul CI, Walsh EP, Alexander ME, Webster G, et al. Prospective evaluation of defibrillation threshold and postshock rhythm in young ICD recipients. Pacing Clin Electrophysiol. 2012;35:1487–93.

    Article  Google Scholar 

Download references

Funding

This study was supported by research fund from Chosun University, 2018.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hyung Wook Park.

Ethics declarations

This study was approved by our institutional review board (CNUH-2012-175) and was designed to assess the risk of perioperative complications and estimate the long-term (5 years) clinical event rates.

Conflict of interest

The authors declare that there is no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, S.S., Park, H.W., Jeong, H.K. et al. Defibrillation threshold testing during implantable cardioverter defibrillator implantation: 5-year follow-up. J Interv Card Electrophysiol 60, 485–491 (2021). https://doi.org/10.1007/s10840-020-00733-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10840-020-00733-x

Keywords

Navigation